ifosfamide has been researched along with Bright Disease in 1 studies
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The increased incidence of neoplasia in the chronic use of immunosuppressive agents has been linked to a variety of factors including age, dose, agent, and frequency of administration." | 1.26 | The oncogenic effect of immunosuppressive (cytotoxic) agents in (NZB X NZW) mice. I. Long-term treatment with azathioprine and ifosfamide. ( Fischer, M; Holtz, G; Mitrou, G; Mitrou, PS; Röttger, P, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitrou, PS | 1 |
| Fischer, M | 1 |
| Mitrou, G | 1 |
| Röttger, P | 1 |
| Holtz, G | 1 |
1 other study available for ifosfamide and Bright Disease
| Article | Year |
|---|---|
The oncogenic effect of immunosuppressive (cytotoxic) agents in (NZB X NZW) mice. I. Long-term treatment with azathioprine and ifosfamide.
Topics: Animals; Antibodies, Antinuclear; Azathioprine; Blood Cell Count; Carcinogens; Cyclophosphamide; Dru | 1979 |